Functional assays showed that deficits in the pole test (Figures 5g and h), rotarod test (Figure 5i) and EBST (Figure 5j) were worse after treatment with anti-IL-6 in enriched mice 3 and 4 weeks after stroke. Here, IL6 is linked to stroke disorder.